Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial (Q83971377)
Jump to navigation
Jump to search
scientific article published on 01 December 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial |
scientific article published on 01 December 2003 |
Statements
Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial (English)
Fiorentini G
Rossi S
Lanzanova G
Biancalani M
Palomba A
Bernardeschi P
Dentico P
1 December 2003